Inverse relationship between level of education and risk of cardiovascular disease
1. In this prospective cohort study, educational attainment was inversely associated with cardiovascular disease (CVD) risk, in a dose-response relationship. ...
Tag: cardiovascular risk
Data support targeted approach to cholesterol screening in young adults
1. In the absence of risk factors, there was low prevalence of increased ASCVD risk in women under 50 and ...
Mixed cardiovascular benefit with PCSK9 inhibitior bococizumab: The SPIRE trial
1. When added to statin therapy, the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor bococizumab significantly reduced the risk of ...
Midlife vascular risk factors linked with higher brain amyloid in later life
1. In this prospective cohort study, the presence of vascular risk factors during midlife were associated with higher brain amyloid ...
Cardiovascular outcomes are similar for arthritis patients treated with selective and nonselective NSAIDs
1. Patients with arthritis treated with celecoxib experienced cardiovascular (CV) outcomes at a rate noninferior to those treated with ibuprofen ...
Semaglutide reduces cardiovascular risk in diabetics: The SUSTAIN-6 trial
1. The two-year risk of developing cardiovascular death, nonfatal myocardial infarction (MI) or stroke was approximately 25% less in patients ...
No survival benefit with ICDs in non-ischemic systolic heart failure: The DANISH trial
1. No significant difference in overall mortality was found between the implantable cardioverter-defibrillator (ICD) group and the control group. 2. ...
Reducing LDL-C reduces subsequent cardiovascular risk
1. Medications that lower low-density lipoprotein cholesterol levels, including statins and non-statins alike, provided similarly reduced risks of major vascular ...
Liraglutide associated with lower incidence of death from CV causes in type 2 diabetics
1. Patients with type 2 diabetes who received liraglutide were observed to have a significantly lower incidence of the composite ...
ACE-inhibitor use associated with decreased conduction system disease
1. In this secondary analysis of the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT), lisinopril was associated ...
